The global whole exome sequencing market is estimated to be valued at USD 2.07 Bn in 2025 and is expected to reach USD 5.51 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 15.0% from 2025 to 2032.
To learn more about this report, Request sample copy
The whole exome sequencing industry is expected to witness significant growth during the forecast period. This is mainly due to the increasing applications of whole exome sequencing in various medical domains like oncology, cardiology, and prenatal diagnosis. Whole exome sequencing assists in identifying the mutations and variations in all the protein coding genes. This helps medical professionals to accurately diagnose various genetic conditions and take correct treatment decisions. Moreover, reducing costs of whole exome sequencing technologies is also supporting the adoption of these techniques in clinical settings and biomedical research. Key market players such as Genomatix GmbH are further investing in research and development to launch accurate and affordable whole exome sequencing products, which is anticipated to propel the market growth in the coming years.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients